uniQure N.V.

NASDAQ:QURE   3:59:59 PM EDT
28.85
-0.16 (-0.55%)
Mergers / Acquisitions

uniQure To Acquire Corlieve Therapeutics And Advance Its Gene Therapy Program To Treat Temporal Lobe Epilepsy

Published: 06/22/2021 16:09 GMT
uniQure N.V. (QURE) - Uniqure to Acquire Corlieve Therapeutics and Advance Its Gene Therapy Program to Treat Temporal Lobe Epilepsy (tle).
Uniqure NV - Under Terms of Agreement, Uniqure Will Pay EUR 46.3 Million in an Upfront Payment of Cash to Acquire Corlieve.